Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NICOLHON - Pilot Study of the Efficacy of Nicotinamide (Vitamin B3) in Leber's Hereditary Optic Neuropathy

NCT07258667 is registered in ClinicalTrials.gov with University Hospital, Angers as lead sponsor.

NCT NCT07258667
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07258667 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NICOLHON - Pilot Study of the Efficacy of Nicotinamide (Vitamin B3) in Leber's Hereditary Optic Neuropathy
Lead sponsor
University Hospital, Angers
Phase
Phase 1
Overall status
Not yet recruiting
Start date
April 30, 2026
Completion date
April 30, 2028
Enrollment
13 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leber hereditary optic neuropathy (lhon), leber's hereditary optic neuropathy (lhon), mitochondrial disease, optic nerve disease